Why is Natco Pharma falling/rising?

As of 06-Nov, Natco Pharma Ltd. is experiencing a decline in its stock price, currently at Rs 800.45, which reflects a decrease of Rs 19.7 or 2.4%. The stock has been underperforming, having lost 3.69% over the last two days and is trading below all key moving averages, indicating a bearish trend. Additionally, the stock's performance over the past week shows a decline of 3.92%, while it has significantly underperformed the benchmark Sensex, which has gained 1.86% over the past month. Notably, despite the recent price drop, there has been an increase in investor participation, with delivery volume rising by 20.62% against the five-day average, suggesting some level of interest despite the falling price.
Broader Market Context: In the context of the broader market, Natco Pharma's recent performance contrasts sharply with the Sensex, which has shown positive returns of 6.62% year-to-date and 3.65% over the past year. The stock's year-to-date decline of 42.29% and one-year decline of 44.72% further highlight its struggles relative to the market. This underperformance may be attributed to a combination of negative sentiment surrounding the stock and broader market conditions that favor other sectors, as evidenced by the Sensex's positive trajectory. The lack of available positive or negative factors in the dashboard limits the analysis of specific catalysts affecting Natco Pharma's recent price movements.